Amy L. Burroughs - 05 Dec 2024 Form 4 Insider Report for Terns Pharmaceuticals, Inc. (TERN)

Role
Chief Executive Officer, Director
Signature
/s/ David Strauss, as Attorney-in-Fact for Amy L. Burroughs
Issuer symbol
TERN
Transactions as of
05 Dec 2024
Net transactions value
+$110,468
Form type
4
Filing time
09 Dec 2024, 18:04:56 UTC
Previous filing
21 Oct 2024
Next filing
03 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TERN Common Stock Purchase $110,468 +15,450 +423% $7.15 19,099 05 Dec 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 3,649 shares acquired by the reporting person under the Issuer's 2021 Employee Stock Purchase Plan ("ESPP") on November 30, 2024.